Seamlessly Integrated

Strategy Consulting &
Transaction Advisory Services

For the Life Sciences Industry

More About Us Play the Back Bay Video

A Rare-Disease Approach to Seizure Treatment

The latest white paper by Back Bay Life Science Advisors looks at how and why biopharmaceutical companies are looking to subsets of syndromes within the epilepsies, and focusing on smaller, underserved patient pools with high unmet need with the expectation that the broader epilepsy community may ultimately benefit.


Effective Strategy and Partnering Approaches For University-Generated IP

This white paper explores the issue of the “have” versus “have-nots” in the academic-industry partnering landscape and offers specific solutions to increase productivity and investment returns. With valuable insight from our peers at Vantage Partners, we look at data that point to the top one percent of research universities absorbing most of the revenue from commercialization of university-generated IP – and what can be done about it.

Results Matter